HOLLINGS RENTON
CIK 1187333 · President and CEO · last filed 2026-04-22
HOLLINGS RENTON is a President and CEO who has filed 83 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for ANAB, was dated Apr 22, 2026. Across all open-market trades the lifetime net is −$15.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $852.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$852.0K
8
83
-$15.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANAB | Director | 15,196 | $56.07 | $852.0K | -$1.37M | 18 | 2026-04-22 |
| ZYME | Director | — | $22.88 | — | $0 | 5 | 2023-12-08 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 0 | — | — | -$875.4K | 14 | 2020-07-02 |
| CEPHEID (CPHD) Delisted | Director | 0 | — | — | -$4.29M | 23 | 2016-11-07 |
| KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Director | — | — | — | $0 | 3 | 2015-10-02 |
| RIGL | Director | — | $32.85 | — | $0 | 7 | 2013-05-28 |
| AFFYMAX INC (AFFY) Delisted | Director | — | — | — | $0 | 4 | 2012-06-18 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | President and CEO | 232,490 | — | — | -$8.55M | 9 | 2008-02-26 |
Recent Filings
83 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-22 | ANAB | Mixed | — | $0 | EDGAR |
| 2026-01-08 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2025-08-12 | ANAB | Mixed | — | -$129.8K | EDGAR |
| 2025-07-03 | ANAB | Mixed | — | -$348.2K | EDGAR |
| 2025-06-20 | ANAB | Sell (S) | −3,015 | -$72.3K | EDGAR |
| 2025-06-17 | ANAB | Exer (M) | +6,030 | $0 | EDGAR |
| 2025-01-07 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2024-12-03 | ANAB | Mixed | — | -$180.7K | EDGAR |
| 2024-07-17 | ANAB | Mixed | — | -$237.1K | EDGAR |
| 2024-06-18 | ANAB | Mixed | +1,950 | -$45.2K | EDGAR |